Business
CURE Pharmaceutical to Present at LD Micro on December 15, Schedules Investor Video Webcast for December 17
OXNARD, Calif.--(BUSINESS WIRE)-- CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of
About this update from Currenc Group Inc.
[{"type":"text","content":" OXNARD, Calif.--(BUSINESS WIRE)--\nCURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, today announced that management will present on the company at the LD Micro Main Event Conference on Tuesday, December 15, 2020 at 11:00 AM Pacific Time. Additionally, the Company will host a video webcast with the investment community on Thursday, December 17, 2020, at 4:00 p.m. Eastern Standard Time\n\nOn the Investor Video Webcast, Rob Davidson, CEO of CURE, Nancy Duitch, CEO of wholly-owned subsidiary The Sera Labs and Chief Strategy Officer for the Company, and Mike Redard, CFO of CURE, will present on the Company’s strategic positioning among other topics and will address shareholder questions at the end of the webcast. To register for this webcast, please use the below web link.\n\nhttps://zoom.us/webinar/register/WN_BrUIQ-jlR0OkoNC8GNCnhg\n\nIf you have questions during or prior to the webcast, please send an email to [email protected] with \"CURR Question\" in the subject line by 6 p.m. Eastern Standard Time on Tuesday, December 15. The executives will answer as many questions as time will allow. For those unable to participate in the live webcast, an archived version of the webcast will be available on the investor relations section of the company's website in the following days.\n\nInvestors interested in attending the LD Micro Main Event Conference can get more information here: https://ve.mysequire.com/.\n\nAbout Sera Labs\n\nSera Labs® is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting edge technology and superior ingredients such as CBD. Sera Labs creates high-quality products that use science-backed, proprietary formulations. Its more than 20 products are sold under the brand names SeraRelief™, SeraTopical™, SeraLabs™, Gordon’s Herbals™ and SeraPets™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health & wellness, and pet care, Sera Labs products are sold in major national drug, grocery chains and mass retailers. The company also sells products under private label to major retailers and multi-level marketers, as well as direc...